BRITISH PROSTATE GROUP HOME PAGE

Welcome to the British Prostate Group web site, The British Prostate Group (BPG) is a registered charity (charity number 1055115) established for the public benefit to promote research into diseases of the prostate gland such as BPH, prostatitis and prostate cancer and to publish and disseminate results of such research. The British Prostate Group aims to raise public awareness of the need for research and also ensure successful research.

BPG Origins

The origin of the British Prostate Group was an informal group of urologists and scientists interested in prostate research and clinical development that first met in the Tenovus Institute for Cancer Research in Cardiff in 1973. In the late 1970's interest in the prostate had grown considerably with many younger urologists expressing an active interest in the British Prostate Group. The BPG now has over 140 members and a great deal of support from industry.

BPG Activities

Diseases affecting the prostate are now increasing, and 21,000 men in England and Wales develop the symptoms of prostate cancer each year. Of these around 10,000 men die of the condition. Research and development of new methods is the only way forward to ensure that these numbers decrease. The BPG aims to facilitate this while raising the profile of ALL diseases of the prostate, by organising meetings to coordinate research, bringing clinicians basic scientists and now patient support groups together in a fellowship of mutual cooperation for 2 meetings each year, in locations designed to cover the various regions of the UK. We also organise larger, international symposia, often in collaboration with other related organisations, attracting the very highest quality international speakers to the UK.

BPG Priorities

1. Information

Promote a better understanding of ALL men's health issues
Remove the stigma of men's attitude to health

2. Education

Educate the general public, promote awareness and TRUST of clinical and scientific collaborations
Professional education at undergraduate and postgraduate levels into prostate diseases

3. Promote increased resources

Prioritise funding for patient care (e.g. PSA testing / counselling)
Identify priorities for research and development in academic, clinical, and industrial settings

4. Help to co-ordinate patient support groups by offering multi-disciplinary expert advice